Non-Invasive Treatment of Abdominal Aortic Aneurysm Clinical Trial

PHASE2CompletedINTERVENTIONAL
Enrollment

261

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

July 23, 2019

Study Completion Date

July 23, 2019

Conditions
Aneurysm
Interventions
DRUG

Doxycycline

100 mg po bid

DRUG

Placebo

capsule identical to the doxycycline capsule

Trial Locations (22)

10032

Columbia University Medical Center, New York

17822

Geisinger Medical Center, Danville

21201

University of Maryland Medical Center, Baltimore

33176

Miami Cardiac and Vascular Institute, Miami

33606

University of South Florida Health Center, Tampa

37212

Vanderbilt University Medical Center, Nashville

48109

University of Michigan Medical Center, Ann Arbor

49770

McLaren Northern Michigan, Petoskey

60611

Northwestern University Memorial Hospital, Chicago

63110

Washington University School of Medicine, St Louis

68198

Omaha VAMC, Omaha

University of Nebraska Medical Center, Omaha

75216

University of Texas Southwestern Medical Center, Dallas

84132

University of Utah Health Sciences Center, Salt Lake City

Utah VAMC, Salt Lake City

85724

University of Arizona Medical Center, Tucson

85745

Carondelet Heart & Vascular Institute, Tucson

90033

University of Southern California, Los Angeles

94305

Stanford University, Stanford

97239

Oregon Health Sciences University, Portland

Portland VAMC, Portland

02215

Beth Israel Deaconness Medical Center, Boston

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

University of Maryland, Baltimore

OTHER

NCT01756833 - Non-Invasive Treatment of Abdominal Aortic Aneurysm Clinical Trial | Biotech Hunter | Biotech Hunter